Background and Aims: Long-term lamivudine therapy is required for patients with chronic hepatitis B, because hepatitis reappears frequently after it has withdrawn. However, hepatitis B virus (HBV) ...

Entecavir, a drug approved by the Food and Drug Administration for the treatment of chronic hepatitis B virus (HBV) infection, is not believed to inhibit replication of human immunodeficiency virus ...

August 25, 2010 — Long-term antiviral therapy for 3 years or more with entecavir reverses fibrosis and cirrhosis in patients with chronic hepatitis B virus (HBV) infection, according to a new study ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

The Appraisal Committee considered evidence submitted by the manufacturer of entecavir and a review of this submission by the Evidence Review Group (ERG). The manufacturer approached the initial ...

Long-term mortality outcomes were similar in patients with CHB receiving treatment with entecavir or tenofovir. Patients with chronic hepatitis B (CHB) treated with entecavir vs tenofovir disoproxil ...

Hepatitis B e-antigen (HBeAg)-positive and HBeAg-negative chronic hepatitis B are highly prevalent worldwide, and collectively account for more than two million deaths annually, which are caused by ...

Learn everything you need to know about Entecavir-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Entecavir (Baraclude (1 mg)) is an oral antiviral ...